HealthTech firm InventionMed plans to move to WSE main market

Health tech company InventionMed wants to move its shares to the WSE main market in 2018/2019, the firm’s CEO Tomasz Kierul told ISBnews. The company has no plans for another shares issue, as it has sufficient funds for its current projects and will also apply for EU grants for R&D investments, the CEO stated. InventionMed…

This content is for Silver 6 months, Gold 1 Year and Bronze 2 weeks members only.
Log In Buy Subscription
Pin It